ArticleClinical case reports2021
Recurrent retroperitoneal liposarcoma: A case report and literature review.
Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Liposarcoma of the Spermatic Cord With Signs and Symptoms Mimicking the Inguinal Hernia: A Rare Case Report.Clinical case reports · 2025Article
- Anti-CD137 agonist antibody-independent and clinically feasible preparation of tumor-infiltrating lymphocytes from soft tissue sarcoma and osteosarcoma.Frontiers in immunology · 2025Article
- Global, regional, and national burden of soft tissue and extraosseous sarcomas from 1990 to 2021.Preventive medicine reports · 2024Article
- Extraosseous Plasmacytomas: A Radiologist's Perspective-A Narrative Review of the Literature.Diagnostics (Basel, Switzerland) · 2024Review
- Article
- Article
- Article
- Undifferentiated pleiotropic spermatic duct sarcoma: a surgical surprise in the inguinal canal that calls for attention.Przeglad gastroenterologiczny · 2024Article
- Case Report: Successful R0 resection in locally advanced retroperitoneal sarcomas.Frontiers in surgery · 2024Article
- Surgical resection due to poor outcome of the immunotherapy of a relapsed mediastinal liposarcoma: a case report.Future science OA · 2024Article
- Survival of a patient with five recurrences of retroperitoneal liposarcoma over a period of 13 years: A case report and review.Oncology letters · 2023Article
- Effectiveness of tumor‑treating fields to reduce the proliferation and migration of liposarcoma cell lines.Experimental and therapeutic medicine · 2023Article
- A Systematic Review and Meta-Analysis of Surgery for Retroperitoneal Sarcoma With Vascular Resection.Cureus · 2023Review
- Article
- Article
- Investigation of the Incidence and Geographic Distribution of Bone and Soft Tissue Sarcomas in Canada: A National Population-Based Study.Current oncology (Toronto, Ont.) · 2023Article
- Review
- Common peritoneal disorders: what the physician should know.Przeglad gastroenterologiczny · 2023Review
- Giant mesenteric myxoid liposarcoma: Challenges of diagnosis and treatment.Radiology case reports · 2022Article
- Recurrent retroperitoneal liposarcoma: A case report and literature review.Clinical case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal liposarcoma frequently recurs within 2 years of the initial surgical resection. For the early detection of recurrent retroperitoneal liposarcomas, a shorter follow-up interval with CT or MRI would be helpful.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.